Clinical Trial

A Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SV003 in Healthy Participants.

Name: A Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SV003 in Healthy Participants. — clinical trial record (NCT07469085)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The objective of this clinical study is to evaluate the safety, tolerability, pharmacokinetic, and pharmacodynamic profiles of SV003 in healthy subjects.

Protocol Amendment History 1 change

critical Recruitment opened 2026-04-09

Trial Details

NCT Number	NCT07469085
Lead Sponsor	Shanghai Synvida Biotechnology Co.,Ltd.
Conditions	Healthy Participants
Enrollment	60 participants
Start Date	2026-04-04
Primary Completion	2026-10-31 (estimated)
Study Completion	2027-03-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-08